首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2020年 3期“药物性肝损伤的诊治与研究进展” => 专家论坛 =>2019年欧洲肝病学..
2019年欧洲肝病学会药物性肝损伤指南更新要点和中国实践
Updated key points of the 2019 EASL guidelines for drug-induced liver injury and its practice in China
文章发布日期:2020年02月16日  来源:  作者:禹弘,康红,陈军  点击次数:375次  下载次数:205次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:为进一步了解2019年欧洲肝病学会药物性肝损伤(DILI)指南,阐述了指南的更新要点,并结合我国实际,从DILI类型、草药制剂和膳食补充剂(HDS)导致的DILI、前瞻性研究与回顾性研究、诊断和因果关系评估、危险因素、DILI的特殊表型、免疫检测点抑制剂DILI的管理、抗结核药物停药指征、已进入临床试验的新的DILI生物标志物和DILI治疗药物等进行了概括和评议,指出新版指南对急性和慢性DILI的诊断作了重新定义,对免疫检测点抑制剂及抗结核药物停药标准提出了明确指导意见,并对一些特殊表型的DILI作出了概括,尤其对于HDS导致的DILI予以了高度重视,对我国DILI的诊治具有很好的参考价值。
【Abstract】:To further understand the 2019 EASL Guidelines for drug-induced liver injury (DILI), this article outlined the updated key points of the guidelines and analyzed these points with reference to the reality of China, including the type of DILI, DILI induced by herbs and dietary supplements, prospective versus retrospective studies, diagnosis and causality assessment, risk factors, special phenotypes of DILI, management of DILI induced by immune checkpoint inhibitors, indication for the withdrawal of antitubercular agents, new biomarkers for DILI under clinical research, and therapeutic drugs for DILI. It is pointed out that the new version of the EASL guidelines redefined the diagnosis of acute and chronic DILI, provided detailed management strategies for DILI induced by immune checkpoint inhibitors and criteria for the withdrawal of antitubercular agents, and summarized several special phenotypes of DILI, with an emphasis on DILI induced by herbs and dietary supplements. Therefore, these guidelines have a good reference value for the diagnosis and treatment of DILI in China.
【关键字】:药物性肝损伤; 欧洲; 诊疗准则(主题)
【Key words】:drug induced liver injury; Europe; practice guideline as topic
【引证本文】:YU H, KANG H, CHEN J. Updated key points of the 2019 EASL guidelines for drug-induced liver injury and its practice in China[J]. J Clin Hepatol, 2020, 36(3): 505-508. (in Chinese)
禹弘, 康红, 陈军. 2019年欧洲肝病学会药物性肝损伤指南更新要点和中国实践[J]. 临床肝胆病杂志, 2020, 36(3): 505-508.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号